a demyelinating inflammation of the optic nerve that often occurs in association with multiple sclerosis (MS) and neuromyelitis optica (NMO)
women 2x more than men
4-5 cases per 100,000 people per year in Scandinavia - maybe more frequent in temperate regions
Caucasians more predisposed
1st onset of MS-related cases tends to be at 20-45 yrs
Clinical features
rapid onset visual impairment in one eye (may be bilat) with dyschromatopsia (change in color perception)
usually associated with retro-orbital pain and pain on moving eye, these often precede the visual impairment
Uhthoff phenomenon, in which vision loss is exacerbated by heat or exercise
Pulfrich phenomenon, in which objects moving in a straight line appear to have a curved trajectory: Presumably caused by asymmetrical conduction between the optic nerves
chronic, relapsing condition with worldwide prevalence of 0.5–4.4 cases per 100,000 people
associated with the presence of a specific serum, NMO IgG autoantibody, which targets the water channel aquaporin-4
thought to be due to autoimmune attack on the astrocytes of the optic nerves and spinal cord causing optic neuritis and spinal cord lesions lead to varying degrees of weakness or paralysis in the legs or arms, loss of sensation, and/or bladder and bowel dysfunction